Invesco Ltd. - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 155 filers reported holding BLUEBIRD BIO INC in Q2 2022. The put-call ratio across all filers is 1.50 and the average weighting 0.0%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q3 2023$270,235
-7.4%
88,893
+0.2%
0.00%
Q2 2023$291,942
+6.0%
88,736
+2.5%
0.00%
Q1 2023$275,410
-95.1%
86,607
-89.3%
0.00%
-100.0%
Q4 2022$5,610,978
-41.6%
810,835
-46.6%
0.00%
-33.3%
Q3 2022$9,614,000
+1137.3%
1,518,679
+709.0%
0.00%
Q2 2022$777,000
+0.5%
187,718
+17.8%
0.00%
Q1 2022$773,000
+2.4%
159,362
+110.9%
0.00%
Q4 2021$755,000
-53.3%
75,545
-10.6%
0.00%
Q3 2021$1,615,000
-37.3%
84,525
+4.9%
0.00%
-100.0%
Q2 2021$2,577,000
+1.3%
80,589
-4.5%
0.00%0.0%
Q1 2021$2,545,000
+6.3%
84,394
+52.5%
0.00%0.0%
Q4 2020$2,395,000
+29.7%
55,347
+61.7%
0.00%0.0%
Q3 2020$1,846,000
-12.5%
34,218
-1.0%
0.00%0.0%
Q2 2020$2,109,000
+20.8%
34,551
-9.1%
0.00%0.0%
Q1 2020$1,746,000
-85.3%
37,996
-71.9%
0.00%
-75.0%
Q4 2019$11,885,000
-87.5%
135,438
-87.0%
0.00%
-84.0%
Q3 2019$95,439,000
-28.8%
1,039,412
-1.4%
0.02%
-28.6%
Q2 2019$134,061,000
+707.4%
1,053,942
+898.6%
0.04%
+483.3%
Q1 2019$16,604,000
+66.7%
105,542
+5.1%
0.01%
+50.0%
Q4 2018$9,961,000
-23.7%
100,405
+12.3%
0.00%0.0%
Q3 2018$13,056,000
-40.3%
89,422
-35.8%
0.00%
-42.9%
Q2 2018$21,858,000
-18.7%
139,266
-11.5%
0.01%
-30.0%
Q1 2018$26,877,000
+7.9%
157,402
+12.6%
0.01%
+11.1%
Q4 2017$24,904,000
-5.5%
139,831
-27.1%
0.01%
-10.0%
Q3 2017$26,358,000
+53.3%
191,906
+17.3%
0.01%
+100.0%
Q2 2017$17,191,000
-18.0%
163,652
-29.0%
0.01%
-28.6%
Q1 2017$20,954,000
+33.3%
230,516
-9.5%
0.01%
+40.0%
Q4 2016$15,718,000
+0.7%
254,748
+10.6%
0.01%0.0%
Q3 2016$15,612,000
+58.0%
230,338
+0.9%
0.01%
+25.0%
Q2 2016$9,884,000
-0.1%
228,344
-1.9%
0.00%0.0%
Q1 2016$9,891,000
-32.2%
232,721
+2.4%
0.00%
-33.3%
Q4 2015$14,598,000
-23.9%
227,322
+1.4%
0.01%
-25.0%
Q3 2015$19,177,000
-54.2%
224,162
-9.8%
0.01%
-50.0%
Q2 2015$41,844,000
+43.9%
248,526
+3.2%
0.02%
+45.5%
Q1 2015$29,086,000
+47.2%
240,829
+11.8%
0.01%
+37.5%
Q4 2014$19,759,000
+732.0%
215,429
+225.5%
0.01%
+700.0%
Q3 2014$2,375,000
+87.9%
66,177
+101.9%
0.00%
Q2 2014$1,264,00032,7700.00%
Other shareholders
BLUEBIRD BIO INC shareholders Q2 2022
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 5,910,687$24,470,0003.71%
Monaco Asset Management SAM 306,142$1,267,0000.55%
Parametrica Management Ltd 90,105$374,0000.41%
Kamunting Street Capital Management, L.P. 55,200$229,0000.31%
Birchview Capital, LP 98,000$406,0000.30%
Kamunting Street Capital Management, L.P. 35,000$145,0000.20%
PDT Partners, LLC 519,477$2,151,0000.19%
Graham Capital Management, L.P. 781,912$3,237,0000.13%
CAXTON ASSOCIATES LP 220,154$911,0000.09%
Baker Brothers Advisors 2,499,715$10,349,0000.06%
View complete list of BLUEBIRD BIO INC shareholders